The latest episode of the “Show Me the Science” podcast focuses on the CDC’s new masking guidelines. Guest William G. Powderly, MD, the Larry J. Shapiro Director of the Institute for Public Health and co-director of the Division of Infectious Diseases at WashU Med, says the new guidelines provide evidence that, for many fully vaccinated […]
Global Health Work in Progress (GHWIP) aims to bring together members of the Washington University global health community to learn about each other’s work.
ACTG Adds First Polyclonal Antibody to ACTIV-2 Outpatient Treatment Study for COVID-19 The AIDS Clinical Trials Group (ACTG), the largest global HIV research network, today announced the addition SAB-185, a polyclonal antibody therapy, to the COVID-19 outpatient treatment study, ACTIV-2 Outpatient Monoclonal Antibodies and Other Therapies Trial. ACTIV-2 includes both phase 2 and phase 3 […]
Gerald Medoff, MD, a physician scientist and one of the founding leaders of the Mycosis Study Group, was the ID Division Director for more than 20 years at Washington University School of Medicine (WUM). Dr. Medoff fostered the first WUSM AIDS Clinical Trials Unit, HIV clinic and HIV/AIDS Advocacy. He provided leadership and training for, […]
The Zika virus that ravaged the Americas, leaving many babies with permanent brain damage, may have a silver lining. The virus can activate immune cells to destroy an aggressive brain cancer in mice, giving a powerful boost to an immunotherapy drug and sparking long-lasting immunological memory that can ward off tumor recurrence for at least […]
RSV infects most children before the age of two and leads to a wide range of disease outcomes from asymptomatic to severe. While host genetic factors for severe outcome are known, viral determinants are not as well defined. ‘Let’s Meet the Virologists’, hosted by Larissa Thackray, PhD, associate professor of Infectious Diseases, talks in Episode […]
The DOLF project is pleased to share several recent publications from clinical trials and community studies of alternative treatments for lymphatic filariasis. All of these have been published with open access. The first two articles (by Campillo et al and Ouattara et al) provide further strong evidence in support of the WHO recommendation to use […]
SHEA is the foremost professional organization promoting health-care epidemiology and infection prevention. As vice chair, Jennie Kwon, DO, MSCI, assistant professor of medicine, will help identify research priorities in health-care epidemiology, encourage new research initiatives in the field, foster research on the prevention and control of health care-associated infections and antibiotic resistance, promote communication and […]
Clinical research is essential for developing optimal intervention and treatments for COVID-19 patients. ‘Let’s Meet the Virologists’, hosted by Larissa Thackray, PhD, associate professor of Infectious Diseases, talks in Episode 25 with Jeannie Kelly, MD, MS, an assistant professor of OB-GYN and Medical Director of Maternal-Fetal Transport and Labor and Delivery, about her work examining […]
Rachel Presti, MD, PhD, an infectious disease physician who led WashU Med’s participation in the Johnson & Johnson/Janssen COVID-19 vaccine trial, encourages the public to take the first vaccine available to them. Presti’s team conducted their clinical trial for several months — as the St. Louis area saw massive spikes in COVID-19 cases — and […]
Comparison of Blood (1->3)-β-D-Glucan Levels in AIDS-Related Pneumocystis jirovecii Pneumonia and AIDS-Related Progressive Disseminated Histoplasmosis. Michael Saccente, Gayathri Krishnan. Clinical Infectious Diseases, ciab277, https://doi.org/10.1093/cid/ciab277. Relevance: Beta D glucan is a noninvasive test used for diagnosis of fungal infections and is helpful in patients with immunosuppressed conditions. Dr. Krishnan et al also published a case report in the Arkansas […]
Miguel Chavez Concha, MD, MSc, first year fellow, is a 2021 recipient of the Jonathan Freeman Scholarship. The award is was established by SHEA to promote the training of outstanding infectious disease fellows who demonstrate interest in the field of healthcare epidemiology. The award is intended to support infection control professionals’ scholarly activities in hospital […]
The virus had not yet left Wuhan, China, when the School of Medicine, Barnes-Jewish Hospital and BJC HealthCare started bracing for a medical disaster of greater magnitude than any they had ever experienced. Six weeks before COVID-19 reached St. Louis, incident command centers were set up at every BJC hospital, with a joint incident command […]
Please come and join us for our inaugural event for Latinx faculty and staff meant for those on the Danforth and Med campus! The first 15 to register will be able to select a lunch option from Fritanga. ¡Salud! Register here. If you have any questions, please contact Julia López, PhD, MPH, LCSW, instructor in […]
New research at Washington University School of Medicine in St. Louis indicates that three new, fast-spreading variants of the virus that causes COVID-19 can evade antibodies that work against the original form of the virus that sparked the pandemic. With few exceptions, whether such antibodies were produced in response to vaccination or natural infection, or […]
The FDA has confirmed a third vaccine is effective and safe in protecting against COVID-19. The vaccine, manufactured by Johnson & Johnson, is overall 67% effective beginning 14 days after vaccination, 77% effective against severe illness and completely effective against death from COVID-19. Efficacy increased over time and was demonstrated against more infectious variants seen in […]
A 2011 report by WHO found UTIs contributed to over 8 million office visits and over 1 million hospitalizations, for an overall annual cost of over $1 billion.
Dennis S. Charney, MD, the Anne and Joel Ehrenkranz Dean and President for Academic Affairs at Mount Sinai Health System announced that Judith Aberg, MD, the Dr. George Baehr Professor of Clinical Medicine, has been appointed Dean of System Operations for Clinical Sciences at the Icahn School of Medicine at Mount Sinai. An internationally renowned […]
Washington University School of Medicine announces a new clinical trial for COVID-19 positive patients, STOP COVID Trial. Many patients testing positive for COVID-19 initially experience mild symptoms, but then clinically deteriorate in the second week of illness. The STOP COVID Trial tests a medication (fluvoxamine) for its anti-COVID properties for individuals ages 30 and up […]